Download PDF

Other users also viewed these articles

Etelcalcetide: What we know eight years since its approval Pedro Freitas, Luciano Pereira
10.1016/j.nefroe.2025.01.010
Etelcalcetide controls secondary hyperparathyroidism and raises sclerostin levels in hemodialysis patients previously uncontrolled with cinacalcet Luciano Artur Lopes Pereira, Catarina Meng, Manuel Augusto Gonçalves Amoedo, Maria Teresa de Sousa Costa Pinto Ferreira Mendes, Marco Alexandre Mateus Prazeres Marques, João Miguel Machado Dória Frazão, André Luiz Loureiro Weigert
10.1016/j.nefroe.2022.11.014
Regression of vascular calcification in a patient treated with cinacalcet: A case report Salgueira, Martínez, Milán
10.3265/Nefrologia.pre2011.M...